Prothena Corp PLC (PRTA)
12.66
+0.25 +2.01%
NASDAQ
Dec 6, 15:15
Delayed 2m
USD
Prothena Sell Recommendations
View 4,000+ financial data types
Browse...
View Full Chart
Sell Recommendations Chart
Historical Sell Recommendations Data
View and export this data going back to 2014.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| Nov. 27, 2019 | Upgrade |
| Nov. 19, 2019 | Upgrade |
| Nov. 14, 2019 | Upgrade |
| Nov. 13, 2019 | Upgrade |
| Nov. 7, 2019 | Upgrade |
| Nov. 6, 2019 | Upgrade |
| Oct. 23, 2019 | Upgrade |
| Oct. 22, 2019 | Upgrade |
| Oct. 9, 2019 | Upgrade |
| Oct. 4, 2019 | Upgrade |
| Sept. 26, 2019 | Upgrade |
| Sept. 17, 2019 | Upgrade |
| Aug. 28, 2019 | Upgrade |
| Aug. 21, 2019 | Upgrade |
| Aug. 16, 2019 | Upgrade |
| Aug. 7, 2019 | Upgrade |
| Aug. 6, 2019 | Upgrade |
| July 3, 2019 | Upgrade |
| June 24, 2019 | Upgrade |
| May 29, 2019 | Upgrade |
| May 16, 2019 | Upgrade |
| May 15, 2019 | Upgrade |
| May 10, 2019 | Upgrade |
| May 9, 2019 | Upgrade |
| May 8, 2019 | Upgrade |
| April 22, 2019 | Upgrade |
| April 8, 2019 | Upgrade |
| March 29, 2019 | Upgrade |
| March 20, 2019 | Upgrade |
| March 9, 2019 | Upgrade |
| March 4, 2019 | Upgrade |
| Feb. 19, 2019 | Upgrade |
| Feb. 16, 2019 | Upgrade |
| Feb. 15, 2019 | Upgrade |
| Nov. 21, 2018 | Upgrade |
| Nov. 18, 2018 | Upgrade |
| Nov. 11, 2018 | Upgrade |
| Nov. 9, 2018 | Upgrade |
| Nov. 8, 2018 | Upgrade |
| Nov. 7, 2018 | Upgrade |
| Aug. 10, 2018 | Upgrade |
| Aug. 9, 2018 | Upgrade |
| Aug. 8, 2018 | Upgrade |
| July 3, 2018 | Upgrade |
| June 29, 2018 | Upgrade |
| June 20, 2018 | Upgrade |
| June 15, 2018 | Upgrade |
| May 25, 2018 | Upgrade |
| May 21, 2018 | Upgrade |
| May 11, 2018 | Upgrade |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
View Sell Recommendations for PRTA
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
Start your free 7-Day Trial.
Start My Free Trial
No credit card required.
Already a subscriber? Sign in.
Sell Recommendations Benchmarks
| Benchmarks | |
|---|---|
| Alkermes PLC | Upgrade |
| Amarin Corp PLC | Upgrade |
| Mainstay Medical International PLC | Upgrade |
Sell Recommendations Range, Past 5 Years
| Minimum | Upgrade | Dec 16 2014 |
| Maximum | Upgrade | Dec 16 2014 |
| Average | Upgrade |
News
Prothena Announces Appointment of Oleg Nodelman to its Board of Directors
Globe Newswire 12/05 16:05 ET
Globe Newswire 12/05 16:05 ET
Evercore downgrades bluebird bio and Clovis in premarket analyst action
SA Breaking News 11/19 08:12 ET
SA Breaking News 11/19 08:12 ET
--Analyst Actions: Evercore ISI Upgrades Prothena to Outperform From In-Line; Price Target is $14
MT Newswires 11/19 08:02 ET
MT Newswires 11/19 08:02 ET
Prothena Reports Third Quarter 2019 Financial Results and Provides R&D Update
Globe Newswire 11/05 16:05 ET
Globe Newswire 11/05 16:05 ET
